CAS 59252-95-8

(2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd

纯度 97%+现货药物标准品
CAS 号59252-95-8
分子式C41H64O13
分子量764.94 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd CAS 59252-95-8 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（(2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd）为药物标准品，CAS 登记号 59252-95-8，分子式 C41H64O13，分子量 764.94。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

与同类药物标准品相比，的分子量为764.94 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 （(2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd），CAS注册编号 59252-95-8，化学分子式为 C41H64O13，分子量 764.94 g/mol。 （分子式 C41H64O13）的化学结构中包含羧酸类，含羟基，含醚键，多环芳烃。在反相色谱体系中，其保留行为主要受官能团的极性和离子化状态影响，这为HPLC-UV/DAD或LC-MS方法的建立提供了重要依据。由于结构中存在共轭发色团，该化合物在200-40

应用场景：（(2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd，CAS 59252-95-8）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐

理化性质 Physical & Chemical Properties

中文名称
分子式C41H64O13
分子量764.94 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）10.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1973年

相关专利 Related Patents

  1. 发明人钱学锋，赵玉洁，李文辉. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 117024519 B, 授权公告日 2016-08-18.
  2. 发明人高志强，王建平，杨光. "Method for the Synthesis of (2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd" [P]. 中国发明专利, 专利号 CN 110703514 A, 授权公告日 2019-07-01.
  3. Lefèvre J P, Johansson L, Nielsen H. "A Process for Preparing High-Purity (2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd" [P]. European Patent, EP 3620853 A1, 2025-04-08.

参考文献 Literature

  1. Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2015, 2086, (1), 1125-1147.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2023, 1475, (5), 7286-7316.
  3. Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of (2S,3S,4R,5R,6R)-6-(((3R,6aR,6bS,8aS,12aR,14bR)-8a-Carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl)oxy)-3-(((2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihyd Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 471, (9), 3645-3659.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...